Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Operating Margin (2020 - 2025)

Pulse Biosciences has reported Operating Margin over the past 4 years, most recently at 23682.56% for Q3 2025.

  • Quarterly results put Operating Margin at 23682.56% for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was 91798.84% (changed N/A YoY), and the annual figure for FY2022 was 8293.86%, down 379286.0%.
  • Operating Margin for Q3 2025 was 23682.56% at Pulse Biosciences, down from 4671.33% in the prior quarter.
  • Over the last five years, Operating Margin for PLSE hit a ceiling of 16250.0% in Q1 2021 and a floor of 23682.56% in Q3 2025.
  • Median Operating Margin over the past 3 years was 2486.59% (2021), compared with a mean of 2558.64%.
  • Biggest five-year swings in Operating Margin: surged 22740105bps in 2021 and later plummeted -2056825bps in 2022.
  • Pulse Biosciences' Operating Margin stood at 1865.62% in 2021, then crashed by -150bps to 4671.33% in 2022, then tumbled by -407bps to 23682.56% in 2025.
  • The last three reported values for Operating Margin were 23682.56% (Q3 2025), 4671.33% (Q2 2022), and 4318.25% (Q1 2022) per Business Quant data.